Skip to main content
logo
Aptus Pharma Limited (BOM:544529)
India flag India · Delayed Price · Currency is INR
339.90
+6.65 (2.00%)
At close: Sep 11, 2026

Aptus Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
5,8292,395----
Market Cap Growth
------
Enterprise Value
5,8912,334----
Last Close Price
339.90139.66----

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
109.2251.85----
PS Ratio
12.525.14----
PB Ratio
24.9710.26----
P/TBV Ratio
25.0510.29----

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
12.655.01----
EV/EBITDA Ratio
79.0331.31----
EV/EBIT Ratio
83.6033.12----

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.310.311.492.722.021.48
Debt / EBITDA Ratio
0.960.962.143.333.374.49
Net Debt / Equity Ratio
0.260.260.742.251.531.17
Net Debt / EBITDA Ratio
0.830.831.062.762.553.56
Net Debt / FCF Ratio
-0.79-0.79-2.09-1.75-3.14-
Asset Turnover
1.421.421.542.202.723.18
Inventory Turnover
2.082.081.732.382.583.52
Quick Ratio
1.021.020.901.040.941.01
Current Ratio
1.831.831.632.031.821.74
Return on Equity (ROE)
30.48%30.48%69.49%56.41%24.95%18.71%
Return on Assets (ROA)
13.46%13.46%17.95%10.62%5.83%4.49%
Return on Invested Capital (ROIC)
17.31%24.55%36.70%22.33%15.03%9.82%
Return on Capital Employed (ROCE)
29.10%29.10%46.60%23.30%15.40%12.40%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
0.79%1.93%----
FCF Yield
-1.34%-3.25%----
Buyback Yield / Dilution
-22.08%-22.08%-224.21%-105.42%0.02%-16.87%